Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 10, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

May 30, 2020

Conditions
Glaucoma; DrugsNormal Tension GlaucomaPrimary Open-angle Glaucoma
Interventions
DRUG

Timolol Maleate

Instillation of one drop in each eye, one-time. Obtaining of OCT angiography scans after 2 hours of instillation.

DRUG

Brimonidine Tartrate

Instillation of one drop in each eye, one-time. Obtaining of OCT angiography scans after 2 hours of instillation.

Trial Locations (1)

19107

Glaucoma Research Center - Wills Eye Hospital, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Optovue

INDUSTRY

lead

Wills Eye

OTHER

NCT03323164 - Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study | Biotech Hunter | Biotech Hunter